Loading...
PhD Robert Roškar

PhD Robert Roškar
no.: 23549 source: ARIS

researcher – active in research organisation
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Drug stability, instrumental analysis in pharmacy
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
1,564.91
A''
210.92
A'
977.43
A1/2
1,321.15
CI10
1,155
CImax
145
h10
17
A1
5.84
A3
2.14
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 81  1,301  1,165  14.38 
Scopus 84  1,463  1,327  15.8 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair of Pharmaceutical technology and Pharmacotherapy 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J2-60047  Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials   1/1/2025 - 12/31/2027  PhD Slavko Kralj   3,552 
2. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections   10/1/2022 - 9/30/2025  PhD Špela Zupančič   6,013 
3. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)   10/1/2022 - 9/30/2025  PhD Martin Petkovšek   3,181 
4. J2-3043  Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases   10/1/2021 - 9/30/2025  PhD Slavko Kralj   4,931 
5. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   10/1/2021 - 9/30/2024  PhD Iztok Grabnar   3,268 
6. J1-9194  Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease   7/1/2018 - 6/30/2022  PhD Julijana Kristl   3,756 
7. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   3/1/2016 - 2/28/2019  PhD Igor Emri   4,742 
8. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)   7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,336 
9. J3-4220  Vloga genetskih polimorfizmov na izid zdravljenja in pojav zapletov pri otrocih z rakom (Slovene)   7/1/2011 - 6/30/2014  PhD Janez Jazbec   3,699 
10. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)   7/1/2011 - 6/30/2014  PhD Albin Kristl   3,339 
11. J3-3615  Farmakogenetski pristop k raziskavam, diagnostiki in terapiji levkemij (Slovene)   5/1/2010 - 4/30/2013  PhD Irena Mlinarič Raščan   2,313 
12. J3-2330  Genetski dejavniki pri osteoporozi (Slovene)   5/1/2009 - 4/30/2012  PhD Janja Marc   2,520 
13. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)   5/1/2009 - 4/30/2012  PhD Nada Kraševec   3,947 
14. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport   2/1/2008 - 1/30/2011  PhD Aleš Mrhar   2,057 
ARIS research and infrastructure programmes Legend
source: ARIS
International projects
no. Code Title Period Head No. of publications
1. CELSA - Cental Europe Leuven Strategic Alliance-Generiranje nanoteles...  Generation of nanobodies against immunomodulating checkpoint receptors in glioblastoma tumor cells   10/1/2020 - 9/30/2022 PhD Ivana Jovchevska    
We were not given permission by the researcher to publish data.
Views history
Favourite